KOD
Kodiak Sciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$91.35
+6.53%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$1.06
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$1.05
- EPS estimate
- -$0.96
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -5.3%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $114
- PT range
- $66 – $145
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.96 | -$1.05 | Miss -9.78% | — |
| May 7, 2026 | -$0.93 | -$0.94 | Miss -1.08% | — |
| Mar 31, 2026 | -$1.02 | -$1.04 | Miss -1.96% | — |
| Nov 13, 2025 | -$1.07 | -$1.16 | Miss -8.41% | — |
| Aug 13, 2025 | -$1.01 | -$1.03 | Miss -1.98% | — |
| May 14, 2025 | -$0.89 | -$1.09 | Miss -22.47% | — |
| Mar 27, 2025 | -$0.90 | -$0.84 | Beat 6.67% | — |
| Nov 14, 2024 | -$0.90 | -$0.84 | Beat 6.67% | — |
| Aug 14, 2024 | -$0.87 | -$0.86 | Beat 1.15% | — |
| May 15, 2024 | -$1.09 | -$0.82 | Beat 24.77% | — |
| Nov 14, 2023 | -$1.41 | -$0.95 | Beat 32.62% | — |
| Aug 14, 2023 | -$1.23 | -$1.53 | Miss -24.39% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026